Clinical Trials List
Protocol NumberBO17706
Not yet recruiting
2005-08-01 - 2008-05-01
Phase III
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳秉聰 Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Wen-Chi Chou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
600 participants
